Impact of Ceftolozane-Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections.

Dana J HolgerNicholas S ReboldSara AlosaimyTaylor MorrisetteAbdalhamid LagnfAna Christine BelzaAshlan J Kunz CoyneAmer El GhaliMichael P VeveMichael J Rybak

Published in: Infectious diseases and therapy (2022)

Our results suggest that C/T is a safe and effective therapeutic regimen for patients with MDR and XDR P. aeruginosa LRTI.

Keyphrases

multidrug resistant
drug resistant
gram negative
respiratory tract
acinetobacter baumannii
pseudomonas aeruginosa
klebsiella pneumoniae
cystic fibrosis
stem cells
mesenchymal stem cells
bone marrow
cell therapy
replacement therapy